Ole Kirk

25.6k total citations · 7 hit papers
228 papers, 16.8k citations indexed

About

Ole Kirk is a scholar working on Infectious Diseases, Emergency Medicine and Epidemiology. According to data from OpenAlex, Ole Kirk has authored 228 papers receiving a total of 16.8k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Infectious Diseases, 86 papers in Emergency Medicine and 61 papers in Epidemiology. Recurrent topics in Ole Kirk's work include HIV/AIDS drug development and treatment (107 papers), HIV/AIDS Research and Interventions (96 papers) and HIV-related health complications and treatments (86 papers). Ole Kirk is often cited by papers focused on HIV/AIDS drug development and treatment (107 papers), HIV/AIDS Research and Interventions (96 papers) and HIV-related health complications and treatments (86 papers). Ole Kirk collaborates with scholars based in Denmark, United Kingdom and Switzerland. Ole Kirk's co-authors include Jens Lundgren, Amanda Mocroft, Peter Reiss, Antonella d’Arminio Monforte, Andrew Phillips, Caroline Sabin, Claus C. Fuglsang, Torben V. Borchert, Bruno Ledergerber and Nina Friis‐Møller and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Ole Kirk

224 papers receiving 16.2k citations

Hit Papers

Decline in the AIDS and death rates in the EuroSIDA study... 1998 2026 2007 2016 2003 2002 2003 2014 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Decline in the AIDS and death rates in the EuroSIDA study: an observational study
    2003 989 citations Amanda Mocroft, Bruno Ledergerber et al. profile →
  2. Industrial enzyme applications
    2002 958 citations Ole Kirk et al. profile →
  3. Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
    2003 802 citations Nina Friis‐Møller, Rainer Weber et al. AIDS profile →
  4. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
    2014 689 citations Lene Ryom, Rainer Weber et al. profile →
  5. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration
    2008 675 citations Caroline Sabin, Signe Westring Worm et al. profile →
  6. One Biocatalyst–Many Applications: The Use of Candida Antarctica B-Lipase in Organic Synthesis
    1998 585 citations Ole Kirk et al. profile →
  7. Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
    2009 481 citations Signe Westring Worm, Caroline Sabin et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Kirk Denmark 60 9.2k 6.6k 5.0k 4.6k 2.8k 228 16.8k
David M. Burger Netherlands 56 9.0k 1.0× 2.0k 0.3× 4.4k 0.9× 3.3k 0.7× 1.1k 0.4× 497 13.4k
David Back United Kingdom 60 8.0k 0.9× 1.8k 0.3× 4.7k 0.9× 2.1k 0.5× 1.3k 0.5× 364 13.4k
Saye Khoo United Kingdom 50 6.0k 0.6× 1.5k 0.2× 3.0k 0.6× 2.1k 0.5× 749 0.3× 331 9.0k
David W. Haas United States 50 4.6k 0.5× 1.4k 0.2× 3.1k 0.6× 2.0k 0.4× 1.0k 0.4× 212 8.7k
Giovanni Di Perri Italy 43 3.8k 0.4× 825 0.1× 1.6k 0.3× 2.2k 0.5× 717 0.3× 418 7.7k
Angela D. M. Kashuba United States 56 6.7k 0.7× 839 0.1× 4.9k 1.0× 2.9k 0.6× 1.1k 0.4× 314 11.2k
Shenghan Lai United States 55 2.1k 0.2× 827 0.1× 1.0k 0.2× 2.1k 0.5× 1.0k 0.4× 229 10.3k
Laurent A. Décosterd Switzerland 50 3.8k 0.4× 673 0.1× 2.2k 0.4× 1.5k 0.3× 1.8k 0.7× 270 10.1k
Raymond F. Schinazi United States 75 11.1k 1.2× 414 0.1× 5.8k 1.2× 7.0k 1.5× 7.3k 2.7× 670 25.9k
Courtney V. Fletcher United States 48 5.5k 0.6× 1.3k 0.2× 4.2k 0.8× 2.1k 0.5× 702 0.3× 230 8.4k

Countries citing papers authored by Ole Kirk

Since Specialization
Citations

This map shows the geographic impact of Ole Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Kirk more than expected).

Fields of papers citing papers by Ole Kirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Kirk. The network helps show where Ole Kirk may publish in the future.

Co-authorship network of co-authors of Ole Kirk

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Kirk. A scholar is included among the top collaborators of Ole Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Kirk. Ole Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Missel, Malene, et al.. (2025). Barriers to Retention in Care among Adults with HIV in Developed Countries: An Integrative Review. AIDS and Behavior. 29(7). 2205–2225.
2.
Croxford, Sara, Nikos Dedes, Enrico Girardi, et al.. (2022). Late diagnosis of HIV: An updated consensus definition. HIV Medicine. 23(11). 1202–1208. 31 indexed citations
3.
Kraef, Christian, Amanda Mocroft, Lars Peters, et al.. (2021). Improving healthcare for patients with HIV, tuberculosis and hepatitis C in eastern Europe: a review of current challenges and important next steps. HIV Medicine. 23(1). 48–59. 10 indexed citations
4.
Kirk, Ole, Nikoloz Chkhartishvili, N Bolokadze, et al.. (2021). Causes and outcomes of hospitalizations among people living with HIV in Georgia’s referral institution, 2012–2017. International Journal of STD & AIDS. 32(7). 662–670. 4 indexed citations
5.
Yilma, Daniel, Alemseged Abdissa, Pernille Kæstel, et al.. (2019). Serum creatinine and estimated glomerular filtration rates in HIV positive and negative adults in Ethiopia. PLoS ONE. 14(2). e0211630–e0211630. 9 indexed citations
6.
Hatleberg, Camilla Ingrid, Lene Ryom, David A Kamara, et al.. (2019). Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study. EClinicalMedicine. 13. 91–100. 17 indexed citations
7.
Wejse, Christian, Troels Lillebæk, Ole Kirk, et al.. (2017). [The current global tuberculosis state].. PubMed. 179(20). 1 indexed citations
8.
Worm, Signe Westring, Mark Bower, Peter Reiss, et al.. (2013). Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study. BMC Infectious Diseases. 13(1). 471–471. 58 indexed citations
9.
Reekie, Joanne, Justyna Kowalska, Igor Karpov, et al.. (2012). Regional Differences in AIDS and Non-AIDS Related Mortality in HIV-Positive Individuals across Europe and Argentina: The EuroSIDA Study. PLoS ONE. 7(7). e41673–e41673. 35 indexed citations
10.
Kowalska, Justyna, Nina Friis‐Møller, Ole Kirk, et al.. (2011). The Coding Causes of Death in HIV (CoDe) Project. Epidemiology. 22(4). 516–523. 111 indexed citations
11.
Friis‐Møller, Nina, Rodolphe Thiébaut, Peter Reiss, et al.. (2010). Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study. European Journal of Cardiovascular Prevention & Rehabilitation. 17(5). 491–501. 283 indexed citations
12.
Nakaoki, Takahiko, Ying Mei, Lisa M. Miller, et al.. (2005). Candida antarctica lipase B catalyzed polymerization of lactones: Effects of immobilization matrices on polymerization kinetics & molecular weight. Industrial Biotechnology. 1(2). 126–134. 27 indexed citations
13.
Cinque, Paola, Amanda Mocroft, Francisco Antunes, et al.. (2004). Changing incidence of CNS HIV-related diseases in the EuroSIDA cohort. Annals of Neurology. 2 indexed citations
14.
Phillips, Andrew, Bruno Ledergerber, Andrzej Horban, et al.. (2004). Rate of viral rebound according to specific drugs in the regimen in 2120 patients with HIV suppression. AIDS. 18(13). 1795–1804. 25 indexed citations
15.
Mocroft, Amanda, Ole Kirk, Nathan Clumeck, et al.. (2004). The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003. Cancer. 100(12). 2644–2654. 102 indexed citations
16.
Mocroft, Amanda, José M. Gatell, Peter Reiss, et al.. (2004). Causes of death in HIV infection. AIDS. 18(17). 2333–2337. 30 indexed citations
17.
Friis‐Møller, Nina, Ole Kirk, Peter Reiss, et al.. (2003). Safety of non-nucleoside reverse transcriptase therapy: data from the EuroSIDA study. UCL Discovery (University College London). 1 indexed citations
18.
Kirk, Ole, Amanda Mocroft, Court Pedersen, et al.. (2000). Infections with Mycobacterium tuberculosis and Mycobacterium avium among HIV-infected Patients after the Introduction of Highly Active Antiretroviral Therapy. American Journal of Respiratory and Critical Care Medicine. 162(3). 865–872. 100 indexed citations
19.
Malaisse, Willy, Hassan Jijakli, Marcel Kadiata, Abdullah Sener, & Ole Kirk. (1997). Stimulation of insulin release by D-glucose pentaacetate. Diabetes. 46(154). 1 indexed citations
20.
Kofod, Hans, Ole Kirk, & Kim Adelhorst. (1996). b‐Cell receptors for glucagon/GLP‐1 exendin(9–39) in mouse islets. Acta Physiologica Scandinavica. 157(3). 347–347. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David M. Burger Breakdown of academic impact, for papers by David Back Breakdown of academic impact, for papers by Saye Khoo Breakdown of academic impact, for papers by David W. Haas Breakdown of academic impact, for papers by Giovanni Di Perri Breakdown of academic impact, for papers by Angela D. M. Kashuba Breakdown of academic impact, for papers by Shenghan Lai Breakdown of academic impact, for papers by Laurent A. Décosterd Breakdown of academic impact, for papers by Raymond F. Schinazi Breakdown of academic impact, for papers by Courtney V. Fletcher
Rankless by CCL
2026